Franklin Resources’s Contineum Therapeutics CTNM Stock Holding History

Franklin Resources’s Portfolio CTNM Stock Details CTNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.1M	Hold	1,839,227	–	–	0.01%	859
2026 Q1	$24M	Sell	1,839,227 -40,140	-2%	-$538K	0.01%	915
2025 Q4	$21.5M	Buy	1,879,367 +223,819	+14%	+$2.55M	0.01%	937
2025 Q3	$19.5M	Sell	1,655,548 -43,277	-3%	-$349K	﹤0.01%	956
2025 Q2	$6.74M	Buy	1,698,825 +122,644	+8%	+$533K	﹤0.01%	1262
2025 Q1	$11M	Buy	1,576,181 +130,616	+9%	+$1.19M	﹤0.01%	1073
2024 Q4	$21.2M	Sell	1,445,565 -1,985	-0.1%	-$31.4K	0.01%	897
2024 Q3	$23.6M	Buy	1,447,550 +820,542	+131%	+$15.7M	0.01%	844
2024 Q2	$11M	Buy	+627,008	New	+$10.1M	﹤0.01%	1037

Other funds holding CTNM

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Franklin Resources's CTNM Position: Q2 2026 in Review

Franklin Resources held its Contineum Therapeutics (CTNM) position steady in Q2 2026 at 1,839,227 shares worth $30.1M. The position accounts for 0.01% of the portfolio, ranked #859.

Franklin Resources first reported a position in CTNM in Q2 2024 and has held it in 9 quarters since. 102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

Franklin Resources held 1,839,227 shares of Contineum Therapeutics worth $30.1M as of Q2 2026.
Franklin Resources left its Contineum Therapeutics share count unchanged in Q2 2026.
Contineum Therapeutics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #859 holding.
Franklin Resources first reported a position in Contineum Therapeutics in Q2 2024 and has held it in 9 quarters since.
102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.